Infra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.50 M
as on 20-12-2024
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.80 M
as on 20-12-2024
- Satisfied Charges ₹ 3.31 M
as on 20-12-2024
- Revenue 13.98%
(FY 2016)
- Profit 0.19%
(FY 2016)
- Ebitda 13.93%
(FY 2016)
- Net Worth 16.27%
(FY 2016)
- Total Assets 4.05%
(FY 2016)
About Infra Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.80 M. The company has closed loans amounting to ₹3.31 M, as per Ministry of Corporate Affairs (MCA) records.
Viswanathan Ramamoorthy and Marysamuel serve as directors at the Company.
- CIN/LLPIN
U24232KL2003PTC015975
- Company No.
015975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Infra Pharmaceuticals Private Limited offer?
Infra Pharmaceuticals Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Infra Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viswanathan Ramamoorthy  | Whole-Time Director | 26-Mar-2005 | Current |
| Marysamuel | Whole-Time Director | 31-Mar-2014 | Current |
Financial Performance of Infra Pharmaceuticals.
Infra Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 13.98% increase. The company also saw a slight improvement in profitability, with a 0.19% increase in profit. The company's net worth Soared by an impressive increase of 16.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Infra Pharmaceuticals?
In 2017, Infra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 May 2020 | ₹0.30 M | Open |
Oriental Bank Of Commerce Creation Date: 04 May 2012 | ₹3.50 M | Open |
Others Creation Date: 01 Jun 2020 | ₹0.56 M | Satisfied |
How Many Employees Work at Infra Pharmaceuticals?
Infra Pharmaceuticals has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
